Biomea Fusion Stock Options

BMEA Stock  USD 3.98  0.08  1.97%   
Biomea Fusion's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 2.22 with a put-to-call open interest ratio of 0.36 over 26 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on April 17th 2025. The total put volume is at 200, with calls trading at the volume of 10.0. This yields a 20.0 put-to-call volume ratio.

Open Interest Against April 17th 2025 Option Contracts

The chart above shows Biomea Fusion's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biomea Fusion's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biomea Fusion's option, there is no secondary market available for investors to trade.

Biomea Fusion Maximum Pain Price Across 2025-04-17 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Biomea Fusion close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Biomea Fusion's option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Biomea Fusion

Analyzing Biomea Fusion's in-the-money options over time can help investors to take a profitable long position in Biomea Fusion regardless of its overall volatility. This is especially true when Biomea Fusion's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Biomea Fusion's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Biomea Fusion's stock while costing only a fraction of its price.
Biomea Fusion's stock options are financial instruments that give investors the right to buy or sell shares of Biomea Fusion common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biomea stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biomea Fusion's stock price goes up or down, the stock options follow.
At present, Biomea Fusion's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 17.1 M, whereas Total Stockholder Equity is forecasted to decline to about 101.6 M.

Biomea Fusion In The Money Call Balance

When Biomea Fusion's strike price is surpassing the current stock price, the option contract against Biomea Fusion stock is said to be in the money. When it comes to buying Biomea Fusion's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Biomea Fusion are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Biomea Current Options Market Mood

Biomea Fusion's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biomea Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Biomea Fusion's options investors are not very successful. Biomea Fusion's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Biomea contract

Base on the Rule 16, the options market is currently suggesting that Biomea Fusion will have an average daily up or down price movement of about 0.14% per day over the life of the 2025-04-17 option contract. With Biomea Fusion trading at USD 3.98, that is roughly USD 0.005522. If you think that the market is fully incorporating Biomea Fusion's daily price movement you should consider buying Biomea Fusion options at the current volatility level of 2.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Biomea Fusion options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Biomea calls. Remember, the seller must deliver Biomea Fusion stock to the call owner when a call is exercised.

Biomea Fusion Option Chain

When Biomea Fusion's strike price is surpassing the current stock price, the option contract against Biomea Fusion stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biomea Fusion's option chain is a display of a range of information that helps investors for ways to trade options on Biomea. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biomea. It also shows strike prices and maturity days for a Biomea Fusion against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
BMEA250417C00002500122.50.65 - 5.01.7In
Call
BMEA250417C00005500505.50.4 - 0.60.6Out
Call
BMEA250417C000050002795.00.6 - 0.70.64Out
Call
BMEA250417C0000450034.50.3 - 4.10.8Out
Call
BMEA250417C0000400054.00.65 - 2.751.0Out
Call
BMEA250417C0000750013807.50.05 - 0.350.3Out
Call
BMEA250417C0001000030810.00.0 - 1.450.15Out
Call
BMEA250417C00012500212612.50.1 - 0.150.15Out
Call
BMEA250417C0001500043215.00.0 - 0.450.2Out
Call
BMEA250417C0001750010717.50.0 - 0.40.69Out
Call
BMEA250417C0002000026320.00.0 - 1.20.1Out
Call
BMEA250417C0002250020722.50.0 - 0.10.3Out
Call
BMEA250417C00025000325.00.0 - 1.00.7Out
 Put
BMEA250417P00002500822.50.0 - 0.40.35Out
 Put
BMEA250417P0000400024.00.6 - 4.81.04In
 Put
BMEA250417P0000350013.50.45 - 3.80.69Out
 Put
BMEA250417P0000550005.51.6 - 2.451.6In
 Put
BMEA250417P000050001715.01.2 - 1.91.55In
 Put
BMEA250417P0000750011837.53.6 - 3.94.0In
 Put
BMEA250417P0001000025610.06.0 - 6.35.5In
 Put
BMEA250417P000125009612.58.1 - 9.18.4In
 Put
BMEA250417P000150009215.010.6 - 11.77.4In
 Put
BMEA250417P00017500017.513.0 - 16.013.0In
 Put
BMEA250417P00020000020.015.6 - 18.515.6In
 Put
BMEA250417P00022500022.518.0 - 21.018.0In
 Put
BMEA250417P00025000025.020.4 - 23.520.4In

Biomea Total Stockholder Equity

Total Stockholder Equity

101.58 Million

At present, Biomea Fusion's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Biomea Fusion Corporate Management

Juan MDChief OfficerProfile
Caroline DupontSenior ContractsProfile
Naomi CretcherChief OfficerProfile
Heow TanChief OfficerProfile
Stephan MDChief OfficerProfile
Franco ValleCFO OfficerProfile
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.93)
Return On Assets
(0.56)
Return On Equity
(1.05)
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.